This roundtable series considers treatment options in the metastatic bladder cancer setting, as discussed by key opinion leaders and participants at virtual live events.
Sacituzumab Govitecan Shows Efficacy in Pretreated Urothelial Cancer
During a Targeted Oncology™ Case-Based Roundtable™ event, Pedro C. Barata, MD, MSc, discussed data supporting the use of sacituzumab govitecan in advanced urothelial carcinoma.
Physicians Discuss Sequencing of Sacituzumab Govitecan in Bladder Cancer
During a Targeted Oncology™ Case-Based Roundtable™ event, Pedro C. Barata, MD, MSc, and participants discussed when in sequence they would use sacituzumab govitecan for patients with metastatic urothelial cancer. This is the second of 2 articles based on this event.
2 Clarke Drive Cranbury, NJ 08512